JPM
57
-5
PNC
52
-3
OI
28
3
DFS
56
-4
VZ
32
-2
NOV
52
3
GPC
29
7
UPS
27
-5
CA
13
3
UNP
42
-4
LLY
37
-2
PRGO
39
-4
CFG
52
-2
FRT
36
2
EMR
50
2
SBUX
36
-3
FCX
65
6
CMG
57
-6
KR
38
-2
CHD
42
-3
JPM
57
-5
PNC
52
-3
OI
28
3
DFS
56
-4
VZ
32
-2
NOV
52
3
GPC
29
7
UPS
27
-5
CA
13
3
UNP
42
-4
LLY
37
-2
PRGO
39
-4
CFG
52
-2
FRT
36
2
EMR
50
2
SBUX
36
-3
FCX
65
6
CMG
57
-6
KR
38
-2
CHD
42
-3
Financhill
Back

Dr Reddy's Laboratories 10K Form

Sell
28

RDY
Dr Reddy's Laboratories

Last Price:
73.91
Seasonality Move:
3.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.37B
Cash Flow: $24.84M
Price / Cash Flow: 1.95
Annual Sales: $4.24
Price / Book: 3.49

Profitability

EPS (TTM): 0.80250
Net Income (TTM): $668.83M
Gross Margin: $1.98B
Return on Equity: 20.73%
Return on Assets: 14.97%

Dr Reddy's Laboratories Earnings Forecast

Key Dr Reddy's Laboratories Financial Ratios

  • The Gross Profit Margin over the past 24 years for RDY is 58.61%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 27.65% of Gross Profit Margin.
  • The Research & Development expenses have been 8.19% of Revenue.
  • The Interest Expense is 3.07% of Operating Income.
  • The Net Earning history of RDY is 19.95% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Dr Reddy's Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 2.55
Quick Ratio: 1.66

Price-to-Earnings

Trailing P/E Ratio: 18.34
Forward P/E Ratio: 3.71

RDY Technical Analysis vs Fundamental Analysis

Sell
28
Dr Reddy's Laboratories (RDY) is a Sell

Is Dr Reddy's Laboratories a Buy or a Sell?